News Conference News ISET 2016 Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired Michael O'Riordan February 10, 2016
News Conference News VEITH 2015 DCBs for Femoropoliteal Disease: What’s Now and What’s Next? Yael L. Maxwell November 19, 2015
News Conference News TCT 2015 Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award October 12, 2015
News Conference News EuroPCR 2015 Studies Provide Encouraging Results for DCB in Long SFA Lesions Caitlin E. Cox May 22, 2015
News Conference News TCT 2014 PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis September 13, 2014
News Conference News EuroPCR 2014 BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions Caitlin E. Cox May 21, 2014
News Conference News TCT 2013 Drug-coated Balloons May Become Standard of Care in ISR October 31, 2013
News Conference News TCT 2013 LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD October 30, 2013
News Conference News TCT 2013 Paclitaxel-Coated Balloons Show Promise in Two Studies October 29, 2013
News Conference News EuroPCR 2013 EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges Caitlin E. Cox May 29, 2013
News Conference News EuroPCR 2013 Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices Jason Kahn May 22, 2013
News Conference News ESC 2012 OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon Caitlin E. Cox August 29, 2012
News Conference News PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis November 27, 2011
News Conference News Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk November 17, 2011
News Conference News EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out May 23, 2011